Pharma Giant Otsuka Teams Up with Alphabet Subsidiary Verily on Longitudinal Depression Registry

Pharma giant Otsuka (OTCMKTS:OTSKY) is teaming up with Alphabet’s life science subsidiary Verily to launch a new longitudinal study to research depression and mental health. The study, called My Mental Health Journey, will use Verily’s technology to collect real-world data from individuals living with depression and mental health disorders. The goal of the research is […]

Verily’s SUD Organization OneFifteen Cuts Ties with Samaritan, Moves Toward Full Provider Status

OneFifteen is moving from a management service organization to a full substance use disorder (SUD) provider, parting ways with its former operating partner, Samaritan Behavioral Health. The decision marks a new chapter for one of the more interesting companies in the SUD space. “We set up OneFifteen as a management services organization and partnered with […]

Inside Google’s Tech-Enabled Approach to Revolutionize Addiction Treatment

Google’s life science-focused sister company Verily has made a bet on a brick-and-mortar opioid use disorder (OUD) treatment center. This comes as the technology conglomerate – along with its parent company and other business segments – continues to move further into behavioral health care. The Alphabet Inc. (Nasdaq: GOOGL) life science subsidiary teamed up with […]